array(1) { [0]=> object(WP_Post)#1927 (24) { ["ID"]=> int(245) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2014-10-06 21:45:51" ["post_date_gmt"]=> string(19) "2014-10-06 21:45:51" ["post_content"]=> string(0) "" ["post_title"]=> string(14) "David C. Adams" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(13) "david-c-adams" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2018-12-10 14:53:15" ["post_modified_gmt"]=> string(19) "2018-12-10 14:53:15" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "" ["menu_order"]=> int(0) ["post_type"]=> string(9) "attorneys" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } }


Longtime Weintraub Client, ThermoGenesis, Issued Press Release Regarding Sale of Common Stock

January 27, 2014

Download: 012714 Private Placement Press release Final.pdf

RANCHO CORDOVA, Calif., January 27, 2014 — ThermoGenesis Corp. (Nasdaq: KOOL) today announced that it has entered into definitive agreements with institutional investors in connection with a private placement of common stock and warrants to purchase common stock. Upon the closing of this financing, ThermoGenesis will receive gross proceeds of approximately $6.67 million resulting from the issuance and sale of approximately 3.33 million shares of common stock at a price per share of $2.00. The purchasers will also receive warrants to purchase up to approximately 1.66 million shares of common stock at an exercise price of $2.81 per share. The warrants are non-exercisable for six months after the closing of the financing and have a term of 5 years.

To view the full press release click the link above.